1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On February 20, 2026, Abony Acquisition Corp. I closed its initial public offering of 23,000,000 units at $10.00 per unit, including 3,000,000 units from the underwriters' full over-allotment exercise, for $230 million in gross proceeds. The full $230 million was placed in a U.S.-based trust account, and the company has not yet selected a business combination target. Shareholders' public funds are held in trust until a business combination, a shareholder-approved redemption, or liquidation, and the company has 24 months from the IPO closing to complete a business combination.
IPO of 23,000,000 units at $10.00 per unit, closed February 20, 2026, for $230 million in gross proceeds
Each unit includes one Class A ordinary share and one-third of one redeemable warrant exercisable at $11.50 per share
Private placement of 695,000 units at $10.00 per unit for $6.95 million to the sponsor, Abony Sponsor I LLC (465,000 units), and BTIG, LLC (230,000 units)
$230 million placed in trust with Continental Stock Transfer & Trust Company; the company has 24 months to complete a business combination
Matador Resources Company priced a private offering of $750 million of 6.000% senior unsecured notes due 2034 at 100% of face value, with closing expected on March 5, 2026. The company plans to use the net proceeds to tender for its $500 million of 6.875% senior notes due 2028 and to repay borrowings under its credit facility, which changes the mix of its debt rather than announcing a new operating result.
Offering: $750 million of 6.000% senior unsecured notes due 2034, priced at 100% of face value on February 26, 2026
Expected closing: March 5, 2026, subject to customary closing conditions
Use of proceeds: cash tender offer for the $500 million outstanding 6.875% senior notes due 2028, plus repayment of credit facility borrowings
Tanger entered a new at-the-market equity program with a maximum gross sales price of $400 million, replacing its February 24, 2025 sales agreement, which it terminated without having issued any shares. The company may sell shares from time to time at its discretion and has no obligation to sell, so the program's dilutive effect depends on future sales that the filing does not quantify.
Maximum aggregate gross sales price under the 2026 Sales Agreement is $400 million.
Sales agents include BofA Securities, Wells Fargo Securities, BTIG, Mizuho, Nomura, Regions, Scotia Capital, TD Securities, and Truist Securities, among others.
Compensation to each sales agent will not exceed 2.0% of gross sales price of issuance shares sold through it.
Company intends to use net proceeds for general corporate purposes, including acquisitions, development, and debt repayment; the 2025 agreement had no shares issued as of February 26, 2026.
Graphic Packaging amended its credit agreement with Bank of America, N.A., as administrative agent, raising the maximum Consolidated Total Leverage Ratio. The company said it requested the change because its decision to aggressively reduce inventory depresses EBITDA and increases the ratio. For shareholders, the amendment loosens debt limits while capping share repurchases at $65 million a year and adding restrictions on acquisitions and investments during the Specified Period.
Maximum leverage ratio rises from 4.25 to 1.00 to 5.00 to 1.00 for quarters ending March 31, 2026 through December 31, 2026, and to 4.75 to 1.00 for quarters ending March 31, 2027 through June 30, 2027
Share repurchases are limited to $65 million on an annual basis during the Specified Period, which ends when quarterly financial statements for the quarter ending September 30, 2027 are delivered
An additional pricing tier applies when the leverage ratio is at or above 4.75 to 1.00, and acquisitions and investments in non-guarantor subsidiaries face added restrictions
On February 24, 2026, Macerich's operating partnership, The Macerich Partnership, L.P., entered a Second Amended and Restated Credit Agreement that provides a $900 million revolving loan facility. The agreement replaces a credit agreement dated September 11, 2023, and lets the borrower increase the facility up to $1.1 billion, subject to lender commitments and other conditions. The facility is secured by mortgages and equity pledges and includes a borrowing base covenant and financial covenants.
Revolving loan facility of $900 million, maturing March 1, 2029, with an option to extend to March 1, 2030.
Facility can be increased to an aggregate $1.1 billion, subject to lender commitments and other conditions.
At signing, the applicable margin was 0.90% for Base Rate loans and 1.90% for Term SOFR loans.
Secured by mortgages on certain wholly-owned assets and pledges of certain equity interests; requires a Borrowing Base Maintenance Covenant.
CNX Resources Corporation completed a private offering of $500 million in 5.875% senior notes due March 1, 2034, on February 26, 2026. The company said it intends to use the net proceeds to tender for and, if needed, redeem its outstanding 6.000% senior notes due 2029, with any shortfall funded from its revolving credit facility, so the deal mainly refinances existing debt.
$500 million aggregate principal of 5.875% senior notes due March 1, 2034, issued under an indenture with UMB Bank, N.A., as trustee
Interest is payable semi-annually on March 1 and September 1, beginning September 1, 2026
Proceeds intended to fund a tender offer for, and if needed the redemption of, the company's 6.000% senior notes due 2029
Notes are redeemable on or after March 1, 2029 at 102.938% of principal, declining to 100% in 2031 and thereafter
Vir Biotechnology entered into an underwriting agreement on February 25, 2026, to sell 17,647,059 shares of common stock at $8.50 per share. The company expects net proceeds of about $141.1 million, or about $162.3 million if underwriters fully exercise their option for additional shares, but the sale adds new shares outstanding, which dilutes existing shareholders.
Offering of 17,647,059 common shares at $8.50 per share, with underwriters led by Goldman Sachs & Co. LLC, Leerink Partners LLC, Evercore Group L.L.C. and Barclays Capital Inc.
Expected net proceeds of approximately $141.1 million, or approximately $162.3 million if the underwriters' option is fully exercised.
Underwriters hold a 30-day option to buy up to 2,647,058 additional shares at the public offering price.
Offering is expected to close on February 27, 2026, subject to customary closing conditions.
AbbVie agreed on February 24, 2026 to sell seven series of senior notes, with total principal of $8.0 billion, to a group of underwriters led by J.P. Morgan, BofA Securities, Morgan Stanley and Wells Fargo. The company expects net proceeds of about $7.95 billion, which it plans to use mainly to repay amounts outstanding under a $4.0 billion 364-day delayed draw term loan facility maturing in May 2026, of which $2.0 billion is currently outstanding.
Seven series of senior notes with total principal of $8.0 billion, maturing from 2028 to 2066
Expected net proceeds of about $7.95 billion after underwriting discounts and estimated offering expenses
Proceeds planned to repay the $4.0 billion 364-day term loan, of which $2.0 billion is outstanding, and for general corporate purposes
Closing expected March 4, 2026, subject to customary closing conditions
On February 26, 2026, Boston Scientific entered three new credit agreements with Wells Fargo as administrative agent and terminated its 2021 revolving credit agreement. The $6.000 billion term loan may be drawn only to fund the pending acquisition of Penumbra, Inc., under a merger agreement dated January 14, 2026, which means the company will take on substantial new debt if the deal closes.
$3.000 billion 2026 Revolving Credit Agreement matures February 26, 2031, with a Maximum Leverage Ratio of 3.75x
$2.000 billion 364-day revolving credit agreement, with a ticking fee accruing 120 days after its effective date
$6.000 billion term loan: $1.000 billion Tranche A and $5.000 billion Tranche B, drawable only at the Penumbra acquisition closing
Prior 2021 revolving credit agreement, as amended through May 10, 2024, was terminated
CenterPoint Energy completed the sale of $650 million of 2.875% Convertible Senior Notes due 2029, including the full $50 million option, with net proceeds of about $641.5 million after discounts and expenses. The notes are senior unsecured debt that can convert into cash, common stock, or both, and the initial conversion price of about $53.61 per share is a 25.0% premium over the February 23, 2026 closing price, so the deal adds debt while creating potential future share dilution of up to 15,155,010 shares.
Aggregate principal of $650 million, including an additional $50 million from the initial purchasers' option, sold in a private offering under Rule 144A.
Notes bear 2.875% interest, payable May 15 and November 15 starting November 15, 2026, and mature May 15, 2029.
Initial conversion price of about $53.61 per share; a maximum of 15,155,010 shares may be issued on conversion.
Indenture is dated February 26, 2026, with The Bank of New York Mellon Trust Company, National Association, as trustee.
Abbott agreed under a pricing agreement dated February 23, 2026, to sell $20 billion of senior notes in several series maturing from 2029 to 2066. The company said it will use the proceeds, with cash on hand and possibly additional borrowings, to pay the consideration for its acquisition of Exact Sciences, repay certain Exact Sciences debt, cover fees and expenses, and for general corporate purposes. Closing of the sale is expected on March 9, 2026, subject to customary conditions.
Total offering of $20 billion across eight series, including $1 billion of floating rate notes due 2029 and $3.75 billion each of 4.650% notes due 2036 and 5.500% notes due 2056
Proceeds intended to fund the Exact Sciences acquisition consideration and repay certain Exact Sciences indebtedness
Closing expected March 9, 2026, subject to customary closing conditions
Teledyne entered into a First Amendment to its Second Amended and Restated Credit Agreement on February 25, 2026, with Bank of America, N.A. as administrative agent. The amendment removes the Secured Overnight Financing Rate (SOFR) adjustment feature, which the original agreement set at 0.10% (ten basis points). The filing is a administrative change to loan terms and does not report any new borrowing amounts or financial results.
Amendment dated February 25, 2026, to the credit agreement originally dated June 10, 2024
Eliminates the SOFR adjustment feature, which was 0.10% (ten basis points) in the original agreement
Bank of America, N.A. serves as administrative agent, swing line lender and L/C issuer
Itron entered into a purchase agreement to sell $700.0 million of 0.00% convertible senior notes due March 15, 2032 in a private offering, and the initial purchasers exercised in full an option for an additional $105.0 million on February 24, 2026. The notes have an initial conversion price of about $123.77 per share, a premium of about 30.0% over the $95.21 closing price on February 23, 2026, and the company paid about $92.8 million for capped call transactions meant to reduce dilution. Shareholders face possible dilution if the notes convert, though the capped calls offset some of that exposure up to a cap price of $190.42 per share.
Principal: $700.0 million initial notes plus $105.0 million option exercised in full on February 24, 2026; the notes pay no regular interest.
Initial conversion price of about $123.77 per share, a 30.0% premium to the $95.21 closing price on February 23, 2026.
Capped call transactions cost about $92.8 million, with a cap price of $190.42 per share.
Company expects to use net proceeds to pay for the capped calls, repurchase about $100.0 million of common stock, and repay its 0.00% convertible notes due 2026.
PPL Corporation completed an offering of 23,000,000 equity units on February 26, 2026, including the full exercise of the underwriters' over-allotment option. Each unit has a $50 stated amount and combines a stock purchase contract with a beneficial interest in remarketable senior notes issued by PPL Capital Funding, Inc. and guaranteed by PPL, so the offering can add future common stock issuance for holders who settle the contracts.
Offering covered 20,000,000 units plus 3,000,000 over-allotment units, for 23,000,000 units in total, completed February 26, 2026.
Each unit has a $50 stated amount and total annual distributions of 7.00%, made up of 2.98% contract adjustment payments and 4.02% note interest.
Stock purchase contracts require holders to buy common stock for $50 in cash no later than February 15, 2029.
Underwriters for the offering were J.P. Morgan Securities LLC, BofA Securities, Inc., Morgan Stanley & Co. LLC and RBC Capital Markets, LLC.
On February 26, 2026, Phillips Edison Grocery Center Operating Partnership I, L.P., a subsidiary, completed an underwritten public offering of $350 million of 4.750% senior notes due March 15, 2033, fully guaranteed by parent Phillips Edison & Company, Inc. The notes were sold at 99.295% of principal, with estimated net proceeds of about $346.5 million, which the company intends to use for general corporate purposes, including repaying its revolving credit facility and term loans.
$350 million principal of 4.750% senior notes, maturing March 15, 2033; interest is payable March 15 and September 15, starting September 15, 2026.
Underwriters paid 99.295% of principal; estimated net proceeds are about $346.5 million after the underwriting discount and fees.
Proceeds are intended for general corporate purposes, including repaying revolver borrowings and term loans.
The issuer may redeem the notes before January 15, 2033 at the greater of par or a make-whole premium, and at par afterward.
On February 26, 2026, NextEra Energy Capital Holdings, a wholly-owned subsidiary of NextEra Energy, sold €1.0 billion of Series X and €750 million of Series Y junior subordinated debentures maturing in 2056. The debt is guaranteed on a subordinated basis by NextEra Energy, so it adds long-term borrowing that ranks behind other obligations and is tied to the parent's credit.
Series X: €1.0 billion principal, 4.20% fixed rate until February 26, 2032, then resets to the Five-Year Swap Rate plus a margin
Series Y: €750 million principal, 4.75% fixed rate until February 26, 2036, then resets on the same five-year cycle
NEECH may redeem Series X debentures beginning in 2031 and Series Y debentures beginning in 2035
Debentures were registered under Securities Act Registration Statement Nos. 333-278184 and related numbers
Entergy Louisiana, LLC sold $750 million of 4.90% bonds due 2036 and $750 million of 5.65% bonds due 2056 under an underwriting agreement dated February 26, 2026, and the sale closed the same day. The bonds were issued under the company's automatic shelf registration statement on Form S-3. The filing describes a debt financing and does not report results or changes in guidance, so it is a routine capital-raising event for the utility's bondholders and parent-level investors.
2036 Bonds: $750 million aggregate principal, 4.90% coupon, due April 15, 2036
2056 Bonds: $750 million aggregate principal, 5.65% coupon, due April 15, 2056
Sale of both series closed on February 26, 2026, under an automatic shelf Form S-3 registration
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.